Vascular endothelial growth factors (VEGFs), initially thought to act specifically on the
vascular system, exert trophic effects on neural cells during development and adulthood …

Parkinson's disease (PD is a progressive neurological disorder characterized by the
degeneration and death of midbrain dopamine and non-dopamine neurons in the brain …

Engrafted mesenchymal stem cells from human deciduous dental pulp (SHEDs) support
recovery from neural insults via paracrine mechanisms that are poorly understood. Here we …

Parkinson's disease (PD) is a progressive neurodegenerative disorder where dopamine
(DA) neurons in the substantia nigra degenerate and die. Since no cure for PD exists, there …

Fibromodulin (FMOD) is known as one of very important extracellular matrix small leucine-
rich proteoglycans. This small leucine-rich proteoglycan has critical roles in the extracellular …

Parkinson's disease (PD) is the second most common neurodegenerative disorder and is
characterized by a spectrum of clinicopathologic signs and a complex etiology. PD results …

Tumor-associated lymphatic vessels (LV) serve as a route of cancer dissemination through
the prometastatic crosstalk between lymphatic endothelial cells (LECs) lining the LVs and …

Intra-arterial neural stem cell (NSC) therapy has the potential to improve long-term outcomes
after stroke. Here we evaluate if pretreatment of NSCs with brain-derived neurotrophic factor …

Vascular endothelial growth factor (VEGF) is an angiogenic factor shown to be a critical
secreted cytokine in tumorigenesis and retinal neovascularization (NV). Currently, there are …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that is
usually fatal within 2–5 years. Unfortunately, the only treatment currently available is riluzole …